Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 3, 2015, Pages

  Pammi, Mohan ^a   Haque, Khalid N ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SM5 1AA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; PENTOXIFYLLINE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; PHOSPHODIESTERASE INHIBITOR;

ADJUVANT THERAPY; ADVERSE EVENT; ALL CAUSE MORTALITY; ANTIBIOTIC THERAPY; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; DISEASE SEVERITY; DRUG EFFECT; ENCEPHALOMALACIA; EVIDENCE BASED MEDICINE; GRAM NEGATIVE SEPSIS; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; PREMATURITY; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROLENTAL FIBROPLASIA; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; ADJUVANT CHEMOTHERAPY; BACTERIAL INFECTIONS; ENTEROCOLITIS, NECROTIZING; MORTALITY; SEPSIS;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BACTERIAL INFECTIONS; CHEMOTHERAPY, ADJUVANT; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LENGTH OF STAY; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS;

EID: 84941952746     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004205.pub3     Document Type: Review

References (44)

1. Adel M, Awad HA, Abdel-Naim AB, Al-Aziz MM. Effects of pentoxifylline on coagulation profile and disseminated intravascular coagulation incidence in Egyptian septic neonates. Journal of Clinical Pharmacy and Therapeutics 2010;35(3):257-65. [PUBMED: 20831528]
2. Akdag A, Dilmen U, Haque K, Dilli D, Erdeve O, Goekmen T. Role of pentoxifylline and/or IgM-enriched intravenous immunoglobulin in the management of neonatal sepsis. American Journal of Perinatology 2014;31:905-12. [PUBMED: 24515621]
3. Ali W, Ahmed P, Bhat MA, Mushtaq AB, Mushtaq S. Pentoxifylline in treatment of sepsis of premature infants. JK Practitioner 2006;13(4):204-7.
4. Lauterbach R, Zembala M. Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. European Journal of Pediatrics 1996;155(5):404-9. [PUBMED: 8741040]
5. Lauterbach R, Pawlik D, Danuta K, Wieslaw K, Ewah K, Marek Z. Effect of immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo controlled, double-blind trial. Critical Care Medicine 1999;27:807-14.
6. Shabaan AE, Nasef N, Shouman B, Nour I, Abd Elhamed A, Abdel-Hady H. Pentoxifylline therapy for late-onset sepsis in preterm infants: A randomized controlled trial. Pediatric Academic Societies Annual Meeting. Vancouver, 2014:Abstract 3570.20.
7. Lauterbach R, Pawlik D, Tomaszcyk B, Cholewa B. Pentoxifylline treatment of sepsis of premature infants: preliminary clinical observations. European Journal of Pediatrics 1994;153(9):672-4. [PUBMED: 7957428]
8. Selim K, Hüseyin C, Ibrahim KH, Hasan BU, Kazim U, Hüseyin K. Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis. The Medical Journal of Malaysia 2004;59(3):391-4. [PUBMED: 15727386]
9. ACTRN12606000257561. Safety and efficacy of pentoxifylline as a treatment for preventing the progression of necrotising enterocolitis in preterm neonates - a randomised, placebo controlled pilot trial. http://apps.who.int/trialsearch/trial.aspx?trialid=ACTRN12606000257561 (accessed 15 May 2014).
10. Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Current Opinion in Infectious Diseases 2006;19(3):290-7. [PUBMED: 16645492]
11. Bacher A, Mayer N, Klimscha W, Oismüller C, Steltzer H, Hammerle A. Effects of pentoxifylline on haemodynamics and oxygenation in septic and non-septic patients. Critical Care Medicine 1997;25(5):795-800. [PUBMED: 9187598]
12. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotising enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 1978;187(1):1-7. [PUBMED: 413500]
13. Bienvenu J, Doche C, Gutowski MC, Lenoble M, Lepape A, Perdrix JP. Production of pro-inflammatory cytokines and cytokines involved in the TH1/TH2 balance is modulated by pentoxifylline. Journal of Cardiovascular Pharmacology 1995;25 Suppl 2:S80-4. [PUBMED: 8699868]
14. Boldt J, Müller M, Heyn S, Welters I, Hempelmann G. Influence of long term continuous intravenous administration of pentoxifylline on endothelial related coagulation in critically ill patients. Critical Care Medicine 1996;24(6):940-6. [PUBMED: 8681595]
15. Caplan MS, Hsueh W. Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor. Journal of Pediatrics 1990;117(1 Pt 2):S47-51. [PUBMED: 2194011]
16. Caplan MS, Sun XM, Hseuh W, Hageman JR. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. Journal of Pediatrics 1990;116(6):960-4. [PUBMED: 2348301]
17. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999;103(4 Pt 1):766-71. [PUBMED: 10103300]
18. Halpern MD, Clark JA, Saunders TA, Doelle SM, Hosseini DM, Stagner AM, et al. Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha. American Journal of Physiology. Gastrointestinal and Liver Physiology 2006;290(4):G757-64. [PUBMED: 16269520]
19. Harris MC, D'Angio CT, Gallagher PR, Kaufman D, Evans J, Kilpatrick L. Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing enterocolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. Journal of Pediatrics 2005;147(4):462-8. [PUBMED: 16227031]
20. Harris E, Schulzke SM, Patole SK. Pentoxifylline in preterm neonates. Pediatric Drugs 2010;12(5):301-11. [PUBMED: 20799759]
21. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
22. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Archives of Ophthalmology 1984;102(8):1130-4. [PUBMED: 6547831]
23. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clinical Microbiology Reviews 2004;17(3):638-80. [PUBMED: 15258097]
24. Krysztopik RJ, Bentley FR, Spain DA, Wilson MA, Garrison RN. Free radical scavenging by lazaroids improves renal blood flow during sepsis. Surgery 1996;120(4):657-62. [PUBMED: 8862374]
25. Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4 million neonatal deaths in the year 2000. International Journal of Epidemiology 2006;35(3):706-18. [PUBMED: 16556647]
26. Levy SB. Antimicrobial resistance: Bacteria on the defence. Resistance stems from misguided efforts to try to sterilize our environment. BMJ 1998;317(7159):612-3. [PUBMED: 9727983]
27. Lin PW, Stoll BJ. Necrotizing enterocolitis. Lancet 2006;368(9543):1271-83. [PUBMED: 17027734]
28. Michetti C, Coimbra R, Hoyt DB, Loomis W, Junger W, Wolf P. Pentoxifylline reduces acute lung injury in chronic endotoxemia. Journal of Surgical Research 2003;115(1):92-9. [PUBMED: 14572778]
29. Ng PC, Li K, Wong RP, Chui K, Wong E, Li G, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Archives of Disease in Childhood. Fetal Neonatal Ed 2003;88(3):F209-13. [PUBMED: 12719394]
30. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
31. Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. European Journal of Pediatrics 1999;158 Suppl 1:S18-22. [PUBMED: 10592094]
32. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 Pt 1):285-91. [PUBMED: 12165580]
33. Stoll BJ. Infections of the neonatal infant. In: Behrman RE, Kliegman RM, Jenson HB editor(s). Nelson Textbook of Pediatrics. 17th Edition. Philadelphia: Saunders, 2004:623-40.
34. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292(19):2357-65. [PUBMED: 15547163]
35. Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatric Infectious Disease Journal 2005;24(7):635-9. [PUBMED: 15999007]
36. Travadi J, Patole S, Charles A, Dvorak B, Doherty D, Simmer K. Pentoxifylline reduces the incidence and severity of necrotizing enterocolitis in a neonatal rat model. Pediatric Research 2006;60(2):185-9. [PUBMED: 16864701]
37. Vilcek J, Lee TH. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. Journal of Biological Chemistry 1991;266(12):7313-6. [PUBMED: 1850405]
38. Volpe JJ. Neurology of the Newborn. 3rd Edition. Philadelphia, London: WB Saunders, 1995.
39. Walsh MC, Kliegman RM. Necrotizing enterocolitis: Treatment based on staging criteria. Pediatric Clinics of North America 1986;33(1):179-201. [PUBMED: 3081865]
40. Wang P, Wood TJ, Ba ZF, Chaudry IH. Pentoxifylline maintains vascular endothelial cell function during hyperdynamic sepsis. Surgery 1996;120(2):367-73. [PUBMED: 8751606]
41. Yang S, Zhou M, Koo DJ, Chaudry IH, Wang P. Pentoxifylline prevents the transition from hyperdynamic to hypodynamic response during sepsis. American Journal of Physiology 1999;277(3 Pt 2):H1036-44. [PUBMED: 10484426]
42. Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldman DA. Hospital-acquired neonatal infections in developing countries. Lancet 2005;365(9465):1175-88. [PUBMED: 15794973]
43. Zeni F, Pain P, Vindimian M, Gay JP, Gery P, Bertrand M, et al. Effects of pentoxifylline on circulating cytokine concentrations and haemodynamics in patients with septic shock: results from a double blind, randomized, placebo controlled study. Critical Care Medicine 1996;24(2):207-14. [PUBMED: 8605790]
44. Haque K, Mohan P. Pentoxifylline for neonatal sepsis. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD004205]